KYMERA THERAPEUTICS INC
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About KYMR
Kymera Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system with a primary focus on immunology. The Company's targeted protein degradation (TPD) platform, which is a small molecule therapeutic modality that engages the body’s natural cellular recycling system to selectively eliminate disease-causing proteins. Its immunology programs target STAT6, IRF5 and IRAK4, each of which addresses targets within validated pathways, providing the opportunity to treat a broad range of diseases. It is developing KT-621 as part of its STAT6 program, which is being evaluated in a Phase I clinical trial in healthy volunteers. It is developing KT-579, which is an investigational, first-in-class, oral degrader of IRF5, a genetically validated transcription factor and a master regulator of immunity.
Find out what a historical investment in KYMERA THERAPEUTICS INC would be worth today using our KYMR stock calculator.
$4.77B
-
0.00%
264
$68.78
$65.24
$0.00
$68.80
$19.45
Ready to start your investing journey with Stake?
Open an accountKYMR FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in KYMR
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in KYMR
on Stake
Buy KYMR from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of KYMR from only US$10 with fractional shares
